Find out more about the wearable medical device for Parkinson’s disease.
New wearable medical device for Parkinson’s disease to launch this year
Author: Johanna Stiefler JohnsonPublished: 25 February 2021
Prep: Cook: Serves:
The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease.
CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks.
Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.”
Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for a commercial launch this year.
For more information about Parkinson’s disease therapies, please visit the EPDA website.
Share this story
Helping people with Parkinson’s “take back control of their brain and body”
We talk to the founder of MyCognitionREAD MORE
Could an Apple smart watch track your Parkinson’s disease symptoms?
Researchers hope the innovation could be used to support cliniciansREAD MORE
How a TikTok video inspired a new pill bottle design for Parkinson’s disease
A simple solution for “an everyday struggle”READ MORE